跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
AZITHROMYCIN FOR INJECTION
Authorized
STANDARD
AZITHROMYCIN FOR INJECTION
generic medical partners inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d4dc3219994a161c
Company
generic medical partners inc
Type
Standard
Approval Details
Approval Id
d4dc3219994a161c
Drug Approval Canada Name
AZITHROMYCIN FOR INJECTION
Product Name
AZITHROMYCIN FOR INJECTION
Status
Marketed
Status Date
2023-03-01
Original Market Date
2023-03-01
Din
02524449
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.12.08
Atc Original
J01FA10 AZITHROMYCIN
Atc Name
j 01 fa 10
Aig Number
0126072006
Company Name
generic medical partners inc
Company Address
1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4
Active Ingredients
AZITHROMYCIN (AZITHROMYCIN DIHYDRATE)
500 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d4dc3219994a161c
Type
Standard
Back to Health Canada Approvals
AZITHROMYCIN FOR INJECTION - Health Canada Drug Approval Details